Evidence map›Paper›PMID 11226381›Full record

ArticleBiochemical pharmacology2001

Increased efficacy of antileishmanial antisense phosphorothioate oligonucleotides in Leishmania amazonensis overexpressing ribonuclease H.

M Mishra, J R Bennett, G Chaudhuri

Abstract read
In one paragraph

Article in Biochemical pharmacology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M MishraDepartment of Microbiology, Meharry Medical College, 1005 D. B. Todd Jr. Blvd., 37208, Nashville, TN, USA.
J R Bennett
G Chaudhuri
Meharry Medical College · US

Funding

THE MOLECULAR BASIS OF BARTONELLA BACILLIFORMIS PATHOGENICITYS06GM008037 · NIGMS · MEHARRY MEDICAL COLLEGE · PI RUCKER, HUBERT K. · 1989 to 2007
$17.5M
DNA ANTISENSE APPROACH AGAINST LEISHMANIASISR01AI042327 · NIAID · MEHARRY MEDICAL COLLEGE · PI CHAUDHURI, GAUTAM · 1998 to 2000
$217k
NIAID NIH HHS 5-R01AI42327-03NIAID NIH HHS R01 AI042327NIGMS NIH HHS 2S06GM08037-24NIGMS NIH HHS S06 GM008037
6 · The paper itself

Abstract

Ribonuclease H (RNase H), an enzyme that cleaves an RNA sequence base-paired with a complementary DNA sequence, is proposed to be the mediator of antisense phosphorothioate oligonucleotide (S-oligo) lethality in a cell. To understand the role of RNase H in the killing of the parasitic protozoan Leishmania by antisense S-oligos, we expressed an episomal copy of the Trypanosoma brucei RNase H1 gene inside L. amazonensis promastigotes and amastigotes that constitutively express firefly luciferase. Our hypothesis was that S-oligo-directed degradation of target mRNA is facilitated in a cell that has higher RNase H activity. Increased inhibition of luciferase mRNA expression by anti-luciferase S-oligo and by anti-miniexon S-oligo in these stably transfected promastigotes overexpressing RNase H1 was correlated to the higher activity of RNase H in these cells. The efficiency of killing of the RNase H overexpressing amastigotes inside L. amazonensis-infected macrophages by anti-miniexon S-oligo was higher than in the control cells. Thus, RNase H appears to play an important role in the antisense S-oligo-mediated killing of Leishmania. Chemical modification of S-oligos that stimulate RNase H and/or co-treatment of cells with an activator of RNase H may be useful for developing an antisense approach against leishmaniasis. The transgenic Leishmania cells overexpressing RNase H should be a good model system for the antisense-mediated gene expression ablation studies in these parasites.

Indexed as

AnimalsAntiprotozoal AgentsBase SequenceDNA, ProtozoanDrug Evaluation, PreclinicalGene ExpressionLeishmaniaLuciferasesMolecular Sequence DataOligonucleotides, AntisenseRibonuclease HRNA, MessengerThionucleosidesTransfectionTrypanosoma brucei bruceiAntiprotozoal AgentsDNA, ProtozoanLuciferasesOligonucleotides, AntisenseRibonuclease HRNA, MessengerThionucleosides

Identifiers

PMID11226381
PMCPMC3088082
OpenAlexW1998349008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.